Newsletter

Dividend Stocks

Here’s How ASX Investors Should Prepare for CGT Changes And The Stocks That Could Become More Lucrative As a Result

For ASX investors, this 'tax time' is the most consequential in years. Australia’s capital gains tax regime is on the verge of its most consequential shift since the Howard government replaced cost‑base indexation with the 50% discount in 1999. As the Albanese government approaches the May 2026 budget under pressure on housing affordability, and with the…

ByNick SundichMay 8, 2026

5 Best ASX Dividend Stocks to Buy in May 2026 Ahead of Tuesday’s RBA Decision

5 Best ASX Dividend Stocks to Buy in May 2026 Before RBA Decision The Reserve Bank meets on Monday and Tuesday, with the decision out on Tuesday afternoon. Markets are pricing roughly a 70-86% probability of a 25 bp hike from 4.10% to 4.35%, the third increase this year. For dividend investors, that's actually useful…

ByUjjwal MaheshwariMay 2, 2026

How To Read a Balance Sheet As An Investor: The 7 Questions Prudent Investors Need to Ask!

Knowing how to read a balance sheet is a key skill investors need to know, because the balance sheet is the most underrated document in an annual report. Most new investors skip straight to earnings - perhaps not knowing how importance the balance sheet is or having an appreciate but not knowing how to read…

ByNick SundichApril 21, 2026

The Iran Ceasefire Rally Is On! But Investors Aren’t Responding In the Right Way

Add a new term to your vocabulary: The Iran Ceasefire Rally. The rally on the ASX yesterday, that saw our bourse rise over 2.5% in its best day in several months, occurred amidst a 2 week suspension of hostilities in Iran. And the ASX was not alone with Asian markets and North American futures rallying,…

ByNick SundichApril 9, 2026

Three ASX Dividend Stocks Worth Buying in April 2026 as Bond Yields Hit 5%

ASX Dividend Stocks to Buy as Bond Yields Hit 5% April is the biggest month on the ASX dividend calendar, but 2026 has changed the equation for income investors. The RBA has now hiked twice this year, most recently on 18 March, pushing the cash rate to 4.10%, and Australian 10-year government bond yields are…

ByUjjwal MaheshwariApril 7, 2026

The Long Goodbye: Why Australian Active Fund Managers Are Running Out of Road

Australian Active Fund Managers are struggling, make no mistake. Hitting home the point yesterday were reports that Ox Capital Management — a boutique emerging markets specialist led by veteran investor Joseph Lai; had entered formal wind-up proceedings on March 27 2026. This wind up was not the first, and likely won't be the last. So each…

ByNick SundichApril 2, 2026

Here Are 6 Questions Investors Need To Ask About Their Portfolio To Get The Best Possible Returns!

There are hard questions investors need to ask about their portfolio every now and again, because anyone telling you there's such a thing as a 'set and forget' investment is wrong. Markets evolve, company fundamentals shift, and macro conditions change, yet many portfolios are left largely unchecked. The most rational approach is to periodically interrogate…

ByNick SundichMarch 31, 2026

BHP, Rio Tinto and Woodside Went Ex-Dividend: Is the Post-Dip a Buying Opportunity?

Ex-dividend pullback: opportunity for investors? BHP (ASX: BHP), Rio Tinto (ASX: RIO) and Woodside Energy (ASX: WDS) all went ex-dividend yesterday, on 5 March 2026. Investors who bought shares from that point will not receive the upcoming dividend payment. The price dip that followed was entirely predictable and mechanical, not a sign that anything is…

ByUjjwal MaheshwariMarch 6, 2026

Best ASX Dividend Stocks in 2026: 5 Payouts That Beat Expectations

ASX Dividend Stocks 2026: The Biggest Surprises This Season This ASX reporting season is telling two very different dividend stories. Miners and banks are handing out bigger payouts than expected, while consumer-facing companies are slashing or scrapping dividends. For income investors, the gap between winners and losers has rarely been this wide. That makes stock selection…

ByUjjwal MaheshwariFebruary 24, 2026

Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$180bn company behind obesity drug Ozempic

Not many 100-year old healthcare stocks see a sudden 30% jump in sales in one year and become the largest capitalised company on their entire continent but Novo Nordisk (CPH: NOVO-B) is one such stock that did just that. Its a Danish drug maker that is behind weight loss drugs Ozempic and Wegovy. For much of…

ByNick SundichJanuary 8, 2026

the Kick-ass Multipurpose WordPress Theme

Dividend Stocks

Here’s How ASX Investors Should Prepare for CGT Changes And The Stocks That Could Become More Lucrative As a Result

5 Best ASX Dividend Stocks to Buy in May 2026 Ahead of Tuesday’s RBA Decision

How To Read a Balance Sheet As An Investor: The 7 Questions Prudent Investors Need to Ask!

The Iran Ceasefire Rally Is On! But Investors Aren’t Responding In the Right Way

Three ASX Dividend Stocks Worth Buying in April 2026 as Bond Yields Hit 5%

The Long Goodbye: Why Australian Active Fund Managers Are Running Out of Road

Here Are 6 Questions Investors Need To Ask About Their Portfolio To Get The Best Possible Returns!

BHP, Rio Tinto and Woodside Went Ex-Dividend: Is the Post-Dip a Buying Opportunity?

Best ASX Dividend Stocks in 2026: 5 Payouts That Beat Expectations

Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$180bn company behind obesity drug Ozempic

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Dividend Stocks

Stocks in Spotlight

Add Your Heading Text Here